E- ISSN: 3023-6215
Radiotherapy in Oligometastatic and Oligoprogressive Disease [Anatol J Med ]
Anatol J Med . 2023; 33(1): 1-6 | DOI: 10.4274/terh.galenos.2021.70487

Radiotherapy in Oligometastatic and Oligoprogressive Disease

Mihriban Erdoğan1, Gönül Demir1, Zeliha Güzelöz1, Ferhat Eyiler1, Cüneyt Ebruli1, Olçun Ümit Ünal2, Murat Keser2, Mustafa Emiroğlu3
1Sağlık Bilimleri Üniversitesi, İzmir Tepecik Eğitim ve Araştırma Hastanesi, Radyasyon Onkolojisi Kliniği, İzmir, Türkiye
2Sağlık Bilimleri Üniversitesi, İzmir Tepecik Eğitim ve Araştırma Hastanesi, Medikal Onkolojisi Kliniği, İzmir, Türkiye
3Sağlık Bilimleri Üniversitesi, İzmir Tepecik Eğitim ve Araştırma Hastanesi, Genel Cerrahi Kliniği, İzmir, Türkiye

Oligometastasis is an intermediate group in the biological spectrum between localized disease and metastatic diseases. In terms of prognosis, it may present with a different course than common stage cases. There are many studies have showing the benefit of aggressive local therapy in these cases. In these studies, local treatment of all metastatic foci was shown to prolong survival in oligometastatic disease with primary control. In this review, the role of radiotherapy in oligometastatic disease is discussed considering studies.

Keywords: Oligometastasis, oligoprogressive disease, radiotherapy, stereotaxic radiotherapy, tereotactic body radiotherapy

Corresponding Author: Zeliha Güzelöz, Türkiye
Manuscript Language: English
×
APA
NLM
AMA
MLA
Chicago
Copied!
CITE
 (22 accesses)
 (881 downloaded)
LookUs & Online Makale